Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older (Q37461977)

20 August 2017

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older (English)

1 reference

20 August 2017

cervix uterine cancer

1 reference

Eduardo L Franco

5

0 references

Joakim Dillner

10

object named as

Joakim Dillner

1 reference

20 August 2017

Daniëlle A M Heideman

11

object named as

Daniëlle A M Heideman

1 reference

20 August 2017

3

Philip E Castle

1 reference

20 August 2017

9

Jack Cuzick

1 reference

20 August 2017

1

Chris J L M Meijer

1 reference

Francesc Xavier Bosch José

20 August 2017

8

object named as

F Xavier Bosch

1 reference

20 August 2017

12

Peter J F Snijders

1 reference

20 August 2017

Johannes Berkhof

2

1 reference

20 August 2017

Albertus T Hesselink

4

1 reference

20 August 2017

Guglielmo Ronco

6

1 reference

20 August 2017

Marc Arbyn

7

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 February 2009

1 reference

International Journal of Cancer

20 August 2017

1 reference

20 August 2017

124

1 reference

20 August 2017

3

1 reference

20 August 2017

516-520

1 reference

Human papillomavirus and Papanicolaou tests to screen for cervical cancer

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assays

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening program

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Results of the first World Health Organization international collaborative study of detection of human papillomavirus DNA.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

HPV-mediated cervical carcinogenesis: concepts and clinical implications

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Management of women who test positive for high-risk types of human papillomavirus: the HART study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Epidemiologic classification of human papillomavirus types associated with cervical cancer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Determination of viral load thresholds in cervical scrapings to rule out CIN 3 in HPV 16, 18, 31 and 33-positive women with normal cytology

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Interlaboratory reliability of Hybrid Capture 2.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Comparison of hybrid capture 2 with in situ hybridization for the detection of high-risk human papillomavirus in liquid-based cervical samples.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

On tests of equivalence via non-unity relative risk for matched-pair design

3 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Risk of high-grade cervical intra-epithelial neoplasia based on cytology and high-risk HPV testing at baseline and at 6-months

3 December 2018

1 reference

12 December 2020

Human papillomavirus and cervical cancer

1 reference

12 December 2020

Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial

1 reference

12 December 2020

Why CIN3 and CIN2 should be distinguished on histological reports

1 reference

12 December 2020

Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types

1 reference

12 December 2020

A study of the impact of adding HPV types to cervical cancer screening and triage tests

1 reference

12 December 2020

Carcinogenicity of human papillomaviruses

1 reference

12 December 2020

Reproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening Setting

1 reference

12 December 2020

Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial

1 reference

12 December 2020

Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial

1 reference

12 December 2020

Identifiers

DOI

10.1002/IJC.24010

1 reference

20 August 2017

1 reference

20 August 2017

1 reference